This Company has 70 M in cash after it pays off ALL its debt. About $1.60 a share
At the present time it has an annual cash flow of 50 M in royalties.They have stopped most of itheir operations therefore they will take most of those royalties down to the bottom line. which means about a buck a share annual income .
Don't really know the value of their present cancer drug Peg-38.From what I hear this could mean major royalty revenue.
My guess is that this company is worth somewhere btw $15-20